EMA "road map" calls for more collaborative approach to drug regulation
27 January 2010
Ian Schofield
The
European Medicines Agency (EMA) has outlined a vision of the future EU regulatory environment where regulators and industry start working together earlier on in the drug development process to improve the chances of approval, and information on discontinued drugs is shared with the scientific community...
Please Login to read the full article.
27 January 2010
Ian Schofield
Please Login to read the full article.
RELATED CONTENT
NEWS
- Leaner agency Infarmed may reduce product prices and cap profits in Portugal
- "Vast" overhaul of EU pharmacovigilance may mean higher industry fees
- US Capitol Capsule: With wish granted, Collins forges ahead with new translational science centre
- US Capitol Capsule: Could another biosimilars fight be a brewin'?
COMMENT
Other Informa Comment
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
